T1	p 73 112	acute nonlymphocytic leukemia in adults
T2	p 419 463	adult acute nonlymphocytic leukemia ( ANLL )
T3	p 628 679	101 eligible cases ( bestatin : 48 , control : 53 )
T4	i 61 69	bestatin
T5	i 146 154	bestatin
T6	i 337 345	bestatin
T7	i 552 560	bestatin
T8	i 649 657	bestatin
T9	i 700 708	bestatin
T10	i 879 887	bestatin
T11	i 1008 1016	Bestatin
T12	o 731 740	remission
T13	o 803 811	survival
T14	o 826 851	prolongation of remission
T15	o 1114 1136	survival and remission
T16	o 1179 1191	side-effects